Moleculin Biotech Inc. (MBRX)
NASDAQ · Healthcare
Moleculin Biotech Inc. Net Income 2016–2025
Moleculin Biotech Inc. annual/quarterly net income history and growth rate from 2016 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Moleculin Biotech Inc. net income for the quarter ending March 31, 2026 was -12.8 M, a 117.56% increase year-over-year.
- Moleculin Biotech Inc. net income for the twelve months ending March 31, 2026 was -62.0 M, a 147.11% increase year-over-year.
- Moleculin Biotech Inc. annual net income for 2025 was -33.6 M, a 28.84% increase from 2024.
- Moleculin Biotech Inc. annual net income for 2024 was -26.0 M, a 12.50% decrease from 2023.
- Moleculin Biotech Inc. annual net income for 2023 was -29.8 M, a 2.56% increase from 2022.
- Moleculin Biotech Inc. annual net income for 2022 was -29.0 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Moleculin Biotech Inc. Net Income — FAQ
Moleculin Biotech Inc. (MBRX) net income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Moleculin Biotech Inc.'s net income?
Moleculin Biotech Inc. (MBRX) reported net income of -$34M for fiscal 2025.
Where can I see MBRX's net income history?
The chart and table above show Moleculin Biotech Inc.'s net income by year and by quarter, including the growth rate.